CFDE Data Portal | Search LINC02577

	Label	Description
	LINC02577 Gene (Entity type)	ENSG00000228742 - long intergenic non-protein coding RNA 2577
	GSE238018 MXRA8 knockout MDA-MB-231 3 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE169617 azacitidine 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE171692 FXN knockdown 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 6 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 5 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE113369 p53 inhibition 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 7 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE165960 MEK inhibition 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE199107 tryptophan 4 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS

LINC02577

ENSG00000228742 - long intergenic non-protein coding RNA 2577

GSE238018 MXRA8 knockout MDA-MB-231 3 v 5 human up

A Gene Set from LINCS

GSE169617 azacitidine 1 v 2 human up

A Gene Set from LINCS

GSE171692 FXN knockdown 1 v 0 human up

A Gene Set from LINCS

GSE77108 saha 6 v 2 human dn

A Gene Set from LINCS

GSE77108 saha 5 v 2 human up

A Gene Set from LINCS

GSE113369 p53 inhibition 2 v 3 human up

A Gene Set from LINCS

GSE239844 crizotinib 7 v 2 human dn

A Gene Set from LINCS

GSE165960 MEK inhibition 2 v 3 human dn

A Gene Set from LINCS

GSE199107 tryptophan 4 v 5 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.